Concepedia
Statistics
Publications
9
Citations
238
H-Index
Active since
1996
Affiliations
Daiichi-Sankyo (Japan)(Current)
Daiichi Sankyo (Germany)
Yumi Kawase is an author at Daiichi-Sankyo (Japan) specializing in pharmacology, drug design, and drug discovery.
Publications per year
1996–2024
Discovery of CS-0777: A Potent, Selective, and Orally Active S1P<sub>1</sub> Agonist
Takahide Nishi, Shojiro Miyazaki, Toshiyasu Takemoto et al. · ACS Medicinal Chemistry Letters · 2011 · 51 citations · Full text
Life Sciences, Immunology, Pharmacology +11
Molecular Recognition of Adenophostin, a Very Potent Ca<sup>2+</sup> Inducer, at the <scp>d</scp>-<i>myo</i>-Inositol 1,4,5-Trisphosphate Receptor
Hitoshi Hotoda, Kazuhiro Murayama, Shuichi Miyamoto et al. · Biochemistry · 1999 · 43 citations
Medicine, Biochemistry, Pharmacology +17
Involvement of sphingosine-1-phosphate and S1P1 in angiogenesis: Analyses using a new S1P1 antagonist of non-sphingosine-1-phosphate analog
Kiyoaki Yonesu, Yumi Kawase, Tatsuya Inoue et al. · Biochemical Pharmacology · 2008 · 37 citations
Medicine, Cell Biology, Pharmacology +12
Discovery of CS-2100, a potent, orally active and S1P3-sparing S1P1 agonist
Tsuyoshi Nakamura, Masayoshi Asano, Yukiko Sekiguchi et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 24 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +5
RS-1748, a Novel CC Chemokine Receptor 4 Antagonist, Inhibits Ovalbumin-Induced Airway Inflammation in Guinea Pigs
Yasuhiro Nakagami, Yumi Kawase, Kazuki Yonekubo et al. · Biological and Pharmaceutical Bulletin · 2010 · 22 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +15
1–5 of 9